Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock ...

Shell ( NYSE: SHEL) -2.5% in Wednesday's trading following its disappointing Q4 update, but UBS nevertheless upgrades shares ...

China has rapidly progressed from a market for carmakers into an ‘innovative hub’ for technologies such as electrification ...

Fintel reports that on January 8, 2025, UBS upgraded their outlook for Novo Nordisk A (NYSE:NVO) from Sell to Buy. Analyst ...

The Swiss bank expects the city’s benchmark index to rise above 20,000 by year-end, implying a gain of 3.7 per cent from ...

Fintel reports that on January 7, 2025, UBS upgraded their outlook for Bank of America Corporation - Preferred Stock ...

The Swiss National Bank will likely report a record full-year profit of around 80 billion Swiss francs ($87.79 billion) for ...

UBS analyst Joshua Stone upgraded Shell (SHEL) to Buy from Neutral with a price target of 3,000 GBp, up from 2,800 GBp. Shell now has the ...

Deutsche Bank analyst Benjamin Goy raised the firm’s price target on UBS (UBS) to CHF 29 from CHF 27 and keeps a Hold rating on the shares.Stay ...

UBS expects the S&P 500 to reach 6,600 by the end of this year. In comparison, Citi, Morgan Stanley, Goldman Sachs and ...

European shares dipped on Wednesday, as bond yields surged after investors priced in fewer interest rate cuts in Europe and ...

Investing.com - Novo Nordisk (CSE: NOVOb ) remains the "most exciting growth story" in the European pharmaceutical sector and ...